{
  "trial_id": "NCT02561130",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, duration of type 2 diabetes diagnosis, current anti-diabetic drug regimen, HbA1C levels, body mass index (BMI), ability to perform self-monitoring of capillary blood glucose (SMBG), ability to self-inject insulin, informed consent status, renal function (eGFR), liver function (ALT levels), blood pressure (systolic and diastolic), cardiovascular disease history, oxygen dependence, history of systemic glucocorticoid treatment, history of bariatric surgery, life expectancy, physical activity limitations, alcohol intake history, pregnancy or breastfeeding status, method of birth control, hypersensitivity to study drugs.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Duration of diabetes",
          "duration of type 2 diabetes diagnosis"
        ],
        [
          "Glycated hemoglobin (HbA1C)",
          "HbA1C levels"
        ],
        [
          "Body Mass Index (BMI)",
          "body mass index (BMI)"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Race/Ethnicity",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "current anti-diabetic drug regimen",
        "ability to perform self-monitoring of capillary blood glucose (SMBG)",
        "ability to self-inject insulin",
        "informed consent status",
        "renal function (eGFR)",
        "liver function (ALT levels)",
        "blood pressure (systolic and diastolic)",
        "cardiovascular disease history",
        "oxygen dependence",
        "history of systemic glucocorticoid treatment",
        "history of bariatric surgery",
        "life expectancy",
        "physical activity limitations",
        "alcohol intake history",
        "pregnancy or breastfeeding status",
        "method of birth control",
        "hypersensitivity to study drugs"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, HbA1C, Duration of Diabetes, Blood Pressure, eGFR, Liver Function Tests, Cardiovascular Disease History,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Duration of diabetes",
          "Duration of Diabetes"
        ],
        [
          "Glycated hemoglobin (HbA1C)",
          "HbA1C"
        ],
        [
          "Body Mass Index (BMI)",
          "Body Mass Index"
        ]
      ],
      "remaining_reference_features": [],
      "remaining_candidate_features": [
        "Blood Pressure",
        "eGFR",
        "Liver Function Tests",
        "Cardiovascular Disease History"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Diabetes Diagnosis Duration, Body Mass Index, HbA1c, Systolic Blood Pressure, Diastolic Blood Pressure, eGFR, History of Cardiovascular Disease, History of Hypertension, History of Dyslipidemia, History of Microvascular Complications.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Duration of diabetes",
          "Diabetes Diagnosis Duration"
        ],
        [
          "Glycated hemoglobin (HbA1C)",
          "HbA1c"
        ],
        [
          "Body Mass Index (BMI)",
          "Body Mass Index"
        ]
      ],
      "remaining_reference_features": [],
      "remaining_candidate_features": [
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "eGFR",
        "History of Cardiovascular Disease",
        "History of Hypertension",
        "History of Dyslipidemia",
        "History of Microvascular Complications"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "age, sex, body mass index, HbA1C, duration of type 2 diabetes, number of glucose-lowering agents, systolic blood pressure, diastolic blood pressure, eGFR, ALT levels, history of cardiovascular disease, history of hypoglycemia, smoking status, physical activity level.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Body Mass Index (BMI)",
          "body mass index"
        ],
        [
          "Glycated hemoglobin (HbA1C)",
          "HbA1C"
        ],
        [
          "Duration of diabetes",
          "duration of type 2 diabetes"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Race/Ethnicity",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "number of glucose-lowering agents",
        "systolic blood pressure",
        "diastolic blood pressure",
        "eGFR",
        "ALT levels",
        "history of cardiovascular disease",
        "history of hypoglycemia",
        "smoking status",
        "physical activity level"
      ]
    }
  }
}